Hansson et al. [136] found increased CSF t-Tau levels in MSA and CBS patients compared with PD, and lower t-Tau levels in PSP than MSA and HC, whereas CSF p-Tau levels were significantly lower in MSA and PSP than in controls, but no differences were detected compared with PD patients. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.